Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$23.4K
8.35K shares
What this filing means
SMALES KELLY plans to sell 8.35K shares of TRANSPHORM, INC. valued at approximately $23.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/25/2024ACC: 0001970051-24-000010
8.35K
Shares to sell
$23.4K
Approx. market value
471.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
RSU Common Stock
COMPENSATORY PAYMENT
10/11/2023
471.00Total acquired471.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/11/2023 | RSU Common Stock COMPENSATORY PAYMENT | 471.00 | — |
| Total | 471.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4K
Market value
$10.5K
11/22/2023
—Completed
Units to sell
656.00
Market value
$1.9K
11/20/2023
—Completed
Units to sell
3.23K
Market value
$8.8K
11/17/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
471.00
Market value
$2.3K
1/24/2024
Total
Units
8.35K
Value
$23.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/22/2023 | 4K | $10.5K | — | Completed |
11/20/2023 | 656.00 | $1.9K | — | Completed |
11/17/2023 | 3.23K | $8.8K | — | Completed |
| Planned — Approximate Date | ||||
1/24/2024 | 471.00 | $2.3K | NASDAQ | Planned |
| Total | 8.35K | $23.4K | ||